Injectable chitosan hydrogels for localised cancer therapy

Dhanikula, 1999, Localized paclitaxel delivery, Int. J. Pharm., 183, 85, 10.1016/S0378-5173(99)00087-3 WHO, 2006 Wong, 2007, Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles, Adv. Drug Deliv. Rev., 59, 491, 10.1016/j.addr.2007.04.008 Kumar, 2000, A review of chitin and chitosan applications, React. Funct. Polym., 46, 1, 10.1016/S1381-5148(00)00038-9 Martini, 2003, Sustained release injectable products, Am. Pharm. Rev., 2004 Sinha, 2004, Chitosan microspheres as a potential carrier for drugs, Int. J. Pharm., 274, 1, 10.1016/j.ijpharm.2003.12.026 Ruel-Gariepy, 2000, Characterization of thermosensitive chitosan gels for the sustained delivery of drugs, Int. J. Pharm., 203, 89, 10.1016/S0378-5173(00)00428-2 Chandy, 1990, Chitosan as a biomaterial, Biomater. Artif. Cells Artif. Organs, 18, 1, 10.3109/10731199009117286 Hirano, 1990, A chitosan oxalate gel: its conversion to an N-acetylchitosan gel via a chitosan gel, Carbohydr. Res., 201, 145, 10.1016/0008-6215(90)84231-I He, 1998, In vitro evaluation of the mucoadhesive properties of chitosan microspheres, Int. J. Pharm., 166, 75, 10.1016/S0378-5173(98)00027-1 Henriksen, 1996, Bioadhesion of hydrated chitosans: an in vitro study, Int. J. Pharm., 145, 231, 10.1016/S0378-5173(96)04776-X Ono, 2000, Photocrosslinkable chitosan as a biological adhesive, J. Biomed. Mater. Res., Part A, 49, 289, 10.1002/(SICI)1097-4636(200002)49:2<289::AID-JBM18>3.0.CO;2-M Ishihara, 2006, Chitosan hydrogel as a drug delivery carrier to control angiogenesis, J. Artif. Organs., 9, 8, 10.1007/s10047-005-0313-0 Ruel-Gariepy, 2004, A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel, Eur. J. Pharm. Biopharm., 57, 53, 10.1016/S0939-6411(03)00095-X Chenite, 2001, Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions, Carbohydr. Polym., 46, 39, 10.1016/S0144-8617(00)00281-2 Cho, 2005, Physical gelation of chitosan in the presence of b-glycerophosphate: the effect of temperature, Biomacromolecules, 6, 3267, 10.1021/bm050313s Chenite, 2000, Novel injectable neutral solutions of chitosan form biodegradable gels in situ, Biomaterials, 21, 2155, 10.1016/S0142-9612(00)00116-2 Mi, 1999, Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. I. Effect of phosphorous polyelectrolyte complex and enzymatic hydrolysis of polymer, J. Appl. Polymer Sci., 74, 1868, 10.1002/(SICI)1097-4628(19991114)74:7<1868::AID-APP32>3.0.CO;2-N Mi, 1999, Kinetic study of chitosan-tripolyphosphate complex reaction and acid-resistive properties of the chitosan-tripolyphosphate gel beads prepared by in-liquid curing method, J. Polymer Sci. B Polymer. Phys, 37, 1551, 10.1002/(SICI)1099-0488(19990715)37:14<1551::AID-POLB1>3.0.CO;2-H M. Buschmann, D. Filion, M. Lavertu, Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state, Canada Patent WO 2007/0513112007. Ganguly, 2004, A novel in situ gel for sustained drug delivery and targeting, Int. J. Pharm., 276, 83, 10.1016/j.ijpharm.2004.02.014 Imai, 1991, Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans, Int. J. Pharm., 67, 11, 10.1016/0378-5173(91)90260-U Fiebrig, 1995, Transmission electron microscopy on pig gastric mucin and its interaction with chitosan, Carbohydr. Polym., 28, 239, 10.1016/0144-8617(95)00105-0 Takeuchi, 1996, Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes, Pharm. Res., 13, 896, 10.1023/A:1016009313548 Dash, 1990, Development of a rectal nicotine delivery system for the treatment of ulcerative colitis, Int. J. Pharm., 190, 21, 10.1016/S0378-5173(99)00221-5 Nielsen, 1998, Bioadhesive drug delivery systems I. Characterization of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinooleate, Eur. J. Pharm. Sci., 6, 231, 10.1016/S0928-0987(97)10004-5 Lueben, 1994, Bioadhesive polymers for the peroral delivery of peptides drugs, J. Control. Release, 29, 329, 10.1016/0168-3659(94)90078-7 Engstrom, 1990, Drug delivery from cubic and other lipid-water phases, Lipid Tech., 2, 42 Larsson, 1989, Cubic lipid-water phases. Structures and biomembrane aspects, J. Phys. Chem., 93, 7304, 10.1021/j100358a010 Wyatt, 1992, A cubic-phase delivery system composed of glyceryl monooleate and water for sustained release of water-soluble drugs, Pharm. Tech., 10, 116 Lee, 2005, Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel, Chemotherapy, 51, 311, 10.1159/000088953 Koyano, 1998, Attachment and growth of cultured fibroblast cells on PVA/chitosan-blended hydrogels, J. Biomed. Mater. Res., 39, 486, 10.1002/(SICI)1097-4636(19980305)39:3<486::AID-JBM20>3.0.CO;2-7 Popowicz, 1985, Cultivation of MDCK epithelial cells on chitosan membranes, Biomed. Biochim. Acta, 44, 1329 Ishihara, 2003, Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization, J. Biomed. Mater. Res., 64A, 248, 10.1002/jbm.a.10427 Nativ, 1997, Anti-neoplastic activity of Paclitaxel on experimental superficial bladder cancer: in vitro and in vivo studies, Int. J. Cancer, 70, 297, 10.1002/(SICI)1097-0215(19970127)70:3<297::AID-IJC9>3.0.CO;2-S Manfredi, 1982, Taxol binds to cellular microtubules, J. Cell Biol., 94, 688, 10.1083/jcb.94.3.688 Parness, 1981, Taxol binds to polymerized tubulin in vitro, J. Cell Biol., 91, 479, 10.1083/jcb.91.2.479 Schiff, 1979, Promotion of microtubule assembly in vitro by taxol, Nature, 277, 665, 10.1038/277665a0 Fonseca, 2002, Paclitaxel-loaded PLGA nanoparticles: preparation, physiochemical characterization and in vitro anti-tumoral activity, J. Control. Release, 83, 273, 10.1016/S0168-3659(02)00212-2 Singla, 2002, Paclitaxel and its formulations, Int. J. Pharm., 235, 179, 10.1016/S0378-5173(01)00986-3 Spencer, 1994, Paclitaxel: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer, Drugs, 48, 794, 10.2165/00003495-199448050-00009 Millenbaugh, 1998, Cytostatic and apoptotic effects of paclitaxel in human ovarian tumors, Pharm. Res., 15, 122, 10.1023/A:1011969208114 Mote, 1996, Paclitaxel sensitizes multidrug resistant cells to radiation, Anticancer Drugs, 7, 182, 10.1097/00001813-199603000-00006 Trissel, 1997, Pharmaceutical properties of paclitaxel and their effects on preparation and administration, Pharmacotherapy, 17, 133s Nsereko, 2002, Localized delivery of paclitaxel in solid tumors from biodegradable chitin micropartical formulations, Biomaterials, 23, 2723, 10.1016/S0142-9612(02)00005-4 Herben, 1996, Clinical pharmacokinetics of topotecan, Clin. Pharmacokinet., 31, 85, 10.2165/00003088-199631020-00001 Hsiang, 1985, Captothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I, J. Biol. Chem., 260, 14873, 10.1016/S0021-9258(17)38654-4 Liu, 1989, DNA topoisomerase poisons as antitumor drugs, Annu. Rev. Biochem., 58, 351, 10.1146/annurev.bi.58.070189.002031 Van-Hattum, 2002, The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer, Biochem. Pharmacol., 64, 1267, 10.1016/S0006-2952(02)01297-2 Lerchen, 2001, Design and optimization of 10-O-linked camptothecin glycoconjugates as anticancer agents, J. Med. Chem., 44, 4186, 10.1021/jm010893l Knoght, 1999, Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice, Cancer Chemother. Pharmacol., 44, 177, 10.1007/s002800050965 Gottlieb, 1972, Treatment of malignant melanoma with camptothecin (NSC-100880), Cancer Chemother. Rep., 56, 103 Moertel, 1972, Phase II study of camptothecin (NSC 100880) in the treatment of advanced gastro-intestinal cancer, Cancer Chemother. Rep., 56, 95 Muggia, 1972, Phase I clinical trial of weekly and daily treatment with camptothecin (100880): correlation with pre-clinical studies, Cancer Chemother. Rep., 56, 515 Fassberg, 1992, A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues, J. Pharm. Sci., 81, 676, 10.1002/jps.2600810718 Hertberg, 1989, Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity, J. Med. Chem., 32, 715, 10.1021/jm00123a038 Burke, 1994, The structural basis of camptothecin interactions with human serum albumin: impact on drug stability, J. Med. Chem., 37, 40, 10.1021/jm00027a005 Weingart, 1995, Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the intracranial 9 L aliosarcoma model, Int. J. Cancer, 62, 605, 10.1002/ijc.2910620519 Storm, 2002, Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy, J. Neurooncol., 56, 209, 10.1023/A:1015003232713 Jain, 2000, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, 21, 2475, 10.1016/S0142-9612(00)00115-0 Berrada, 2005, A novel non-toxic camptothecin formulation for cancer chemotherapy, Biomaterials, 26, 2115, 10.1016/j.biomaterials.2004.06.013 Yoo, 2000, In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates, J. Control. Release, 68, 419, 10.1016/S0168-3659(00)00280-7 Arai, 2006, Novel drug delivery system using thermoreversible gelation polymer for malignant glioma, J. Neurooncol., 77, 9, 10.1007/s11060-005-9001-4 Leasniak, 2005, Local delivery of doxorubicin for the treatment of malignant brain tumors in rats, Anticancer Res., 25, 3825 Konishi, 2005, In vivo anti-tumor effect of dual release of ciplatin and adriamycin from biodegradable gelatin hydrogel, J. Control. Release, 103, 7, 10.1016/j.jconrel.2004.11.014 Wong, 2006, Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer, J. Control. Release, 116, 275, 10.1016/j.jconrel.2006.09.007 Minko, 1998, HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a ovarian carcinoma cell line, J. Control. Release, 54, 223, 10.1016/S0168-3659(98)00009-1 Benjamin, 1973, Pharmacokinetics and metabolism of doxorubicin in man, Clin. Pharmacol. Ther., 14, 592, 10.1002/cpt1973144part1592 Lin, 2005, In vitro study of anticancer drug doxorubicin in PLGA-based microparticles, Biomaterials, 26, 4476, 10.1016/j.biomaterials.2004.11.014 Verdiere, 1994, Uptake of doxorubicin from loaded nanoparticles in multidrug resistant leukemic murine cells, Cancer Chemother. Pharmacol., 33, 504, 10.1007/BF00686509 Omelyanenko, 1998, Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate, J. Control. Release, 53, 25, 10.1016/S0168-3659(97)00235-6 Benjamin, 1974, Pharmacokinetics of doxorubicin in patients with sarcomas, Cancer Chemother. Rep., 58, 271 Rahman, 1986, Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes, Br. J. Cancer, 54, 401, 10.1038/bjc.1986.190 Bally, 1990, Studies on the myelosuppression activity of doxorubicin entrapped in liposomes, Cancer Chemother. Pharmacol., 27, 13, 10.1007/BF00689270 Htun, 2004, A negative deviation from Stern-Volmer equation in flourescence quenching, J. Flourescence, 14, 217, 10.1023/B:JOFL.0000016294.96775.fd Han, 2008, A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine, Int. J. Pharm., 350, 27, 10.1016/j.ijpharm.2007.08.014 Jauhari, 2006, A mucoadhesive in situ gel delivery system for paclitaxel, AAPS Pharm. Sci. Tech., 7, 10.1208/pt070253 Obara, 2005, Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice, J. Control. Release, 110, 79, 10.1016/j.jconrel.2005.09.026 Jarry, 2001, Effects of steam sterilization on thermogelling chitosan-based gels, J. Biomed. Mater. Res., 58, 127, 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G Jarry, 2002, Irradiating or autoclaving chitosan/polyol solutions: effect on thermogelling chitosan-b-glycerophosphate systems, Chem. Pharm. Bull., 50, 1335, 10.1248/cpb.50.1335 Ruel-Gariepy, 2002, Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules, J. Control. Release, 82, 373, 10.1016/S0168-3659(02)00146-3 Gendler, 2001, MUC 1, the renaissance molecule, J. Mammary Gland Biol. Neoplasia, 6, 339, 10.1023/A:1011379725811 Hamada, 2004, Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 a marker to predict recurrence, J. Clin. Pathol., 57, 813, 10.1136/jcp.2003.014043 Carreno-Gomez, 1997, Evaluation of the biological properties of soluble chitosan and chitosan microspheres, Int. J. Pharm., 148, 231, 10.1016/S0378-5173(96)04847-8 Murata, 1991, Inhibition of tumor-induced angiogenesis by sulfated chitin derivative, Cancer Res., 51, 22 Chen, 1997, Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment, Cancer Lett, 115, 25, 10.1016/S0304-3835(97)04707-1 Nishimura, 1984, Immunological activity of chitin and its derivatives, Vaccine, 2, 93, 10.1016/S0264-410X(98)90039-1 Tokoro, 1988, Growth-inhibitory effect of hexa-N-acetylchitohexaose and chitohexaose against Meth–A solid tumor, Chem. Pharm. Bull., 36, 784, 10.1248/cpb.36.784 Murata, 1989, Inhibitory effect of chitin heparinoids on the lung metastasis of B16–B16 melanoma, Jpn. J. Cancer Res., 80, 866, 10.1111/j.1349-7006.1989.tb01728.x Hasegawa, 2001, Chitosan induces apoptosis via caspase-3 activation in bladder tumour cells, Jpn. J. Cancer Res., 4, 459, 10.1111/j.1349-7006.2001.tb01116.x Guminska, 1996, In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT), Pol. J. Pharmacol., 48, 495 Ono, 2002, Non-anticoagulant heparin carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumor growth and metastasis to the lung, Br. J. Cancer, 86, 1803, 10.1038/sj.bjc.6600307 Muzzarelli, 1993, Biochemical significance of exogenous chitins and chitosans in animals and patients, Carbohydr. Polym., 20, 7, 10.1016/0144-8617(93)90027-2 Chihara, 1969, Inhibition of mouse sarcoma 180 by polysaccharides from lentinue edodes(Berk.) sing, Nature, 222, 687, 10.1038/222687a0 Kodama, 2002, A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice, Jpn. J. Pharmacol., 90, 357, 10.1254/jjp.90.357 Berger, 2004, Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications, Eur. J. Pharm. Biopharm., 57, 19, 10.1016/S0939-6411(03)00161-9 De-Angelis, 1998, Synthesis and C CP-MAS NMR characterization of a new chitosan-based polymeric network, Macromolecules, 31, 1595, 10.1021/ma971619x Mi, 1999, Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release, Biomaterials, 20, 1603, 10.1016/S0142-9612(99)00064-2 Mi, 2000, Synthesis and characterization of a novel chitosan-based network prepared using naturally occurring crosslinker, J. Polym. Sci., 38, 2804, 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.0.CO;2-Y Yao, 1993, pH sensitivity of hydrogels based on complex forming chitosan: polyether interpenetrating polymer network, J. Appl. Polym. Sci., 48, 343, 10.1002/app.1993.070480218 Yao, 1995, Investigation of pH sensitive drug delivery system of chitosan/gelatin hybrid polymer network, Polym. Int., 38, 77, 10.1002/pi.1995.210380110 Anal, 2006, Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin, Int. J. Pharm., 312, 166, 10.1016/j.ijpharm.2006.01.043 Kim, 1999, Polyelectrolyte complex composed of chitosan and sodium alginate for wound dressing application, J. Biomater. Sci. Polymer Ed., 10, 543, 10.1163/156856299X00478 Yao, 1997, pH-sensitivity of the swelling of a chitosan-pectin polyelectrolyte complex, Macromol. Mater. Eng., 245, 63 Park, 1996, Insoluble polyelectrolyte complex formed from chitosan and a-keratose: conformational change of a-keratose, Macromol. Chem. Phys., 197, 2175, 10.1002/macp.1996.021970709 Long, 1996, Chitosan-carboxymethylcellulose hydrogels as support for cell immobilization, J. Macromol. Sci. Pure Appl. Chem., A33, 1875, 10.1080/10601329608011013 Dumitriu, 2000, Polyionic hydrogels as support for enzyme immobilization, Chitin Enzymology, 2, 527 Wu, 2006, A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate, Int. J. Pharm., 315, 1, 10.1016/j.ijpharm.2006.01.045 Dang, 2006, Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells, Biomaterials, 27, 406, 10.1016/j.biomaterials.2005.07.033 Koyano, 1997, Attachment and growth of cultured fibroblast cells on PVA/chitosan-blended hydrogels, J. Biomed. Mater. Res., 39, 486, 10.1002/(SICI)1097-4636(19980305)39:3<486::AID-JBM20>3.0.CO;2-7 C. Hoemann, A. Chenite, M. Buschmann, A. Sarreqi, J. Sun, Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors, Canada Patent US 2006/01278732006. Bhattarai, 2005, PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release, J. Control. Release, 103, 609, 10.1016/j.jconrel.2004.12.019 Seo, 2001, Atypical pulmonary metastases: spectrum of radiologic findings, Radiographics, 21, 403, 10.1148/radiographics.21.2.g01mr17403